⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2880197 | 0.72 | — | — | |
| SCHEMBL10794995 | 0.72 | — | — | |
| SCHEMBL24832 | 0.71 | — | — | |
| SCHEMBL10939433 | 0.69 | — | — | |
| SCHEMBL7505445 | 0.69 | — | — | |
| SCHEMBL2417531 | 0.68 | — | — | |
| SCHEMBL9593909 | 0.67 | — | — | |
| SCHEMBL9240468 | 0.67 | — | — | |
| SCHEMBL4201234 | 0.67 | — | — | |
| SCHEMBL9816555 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3601296-A1 | 2-OXO-THIAZOLE DERIVATIVES AS A2A INHIBITORS AND COMPOUNDS FOR USE IN THE TREATMENT OF CANCERS | Iteos Therapeutics (BE) | 2020-02-05 | — | — | EP | claimed |
| US-20190276473-A1 | 2-Oxo-Thiazole Derivatives as A2A Inhibitors and Compounds for Use in the Treatment of Cancers | iTeos Belgium SA (BE) | 2019-09-12 | — | — | US | claimed |
| US-10220045-B2 | Compositions and methods for forming stabilized compositions with reduced CSA agglomeration | BRIGHAM YOUNG UNIVERSITY (US) | 2019-03-05 | — | — | US | claimed |
| WO-2018178338-A1 | 2-OXO-THIAZOLE DERIVATIVES AS A2A INHIBITORS AND COMPOUNDS FOR USE IN THE TREATMENT OF CANCERS | ITEOS THERAPEUTICS (BE) | 2018-10-04 | — | — | WO | claimed |
| US-9694019-B2 | Compositions and methods for treating bone diseases and broken bones | BRIGHAM YOUNG UNIVERSITY (US) | 2017-07-04 | — | — | US | claimed |
| EP-3182978-A1 | RADIOLABELED CATIONIC STEROID ANTIMICROBIALS AND DIAGNOSTIC METHODS | Brigham Young University (US) | 2017-06-28 | — | — | EP | claimed |
| US-9603859-B2 | Methods and products for increasing the rate of healing of tissue wounds | BRIGHAM YOUNG UNIVERSITY (US) | 2017-03-28 | — | — | US | claimed |
| US-20160193232-A1 | TREATMENT AND PREVENTION OF MASTITIS | BRIGHAM YOUNG UNIVERSITY (US) | 2016-07-07 | — | — | US | claimed |
| WO-2016029182-A1 | RADIOLABELED CATIONIC STEROID ANTIMICROBIALS AND DIAGNOSTIC METHODS | SAVAGE PAUL B (US) | 2016-02-25 | — | — | WO | claimed |
| US-20160052959-A1 | RADIOLABELED CATIONIC STEROID ANTIMICROBIALS AND DIAGNOSTIC METHODS | BRIGHAM YOUNG UNIVERSITY (US) | 2016-02-25 | — | — | US | claimed |
| EP-1718342-A1 | TECHNETIUM-AND RHENIUM-BIS(HETEROARYL) COMPLEXES, AND METHODS OF USE THEREOF | Molecular Insight Pharmaceuticals, Inc. (US) | 2006-11-08 | — | — | EP | claimed |
| EP-1713515-A1 | TECHNETIUM- AND RHENIUM-BIS(HETEROARYL) COMPLEXES, AND METHODS OF USE THEREOF | Molecular Insight Pharmaceuticals, Inc. (US) | 2006-10-25 | — | — | EP | claimed |
| US-20060034758-A1 | Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof | MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) | 2006-02-16 | — | — | US | claimed |
| US-20060020136-A1 | Phenylcarbazole compounds and organic electroluminescence devices using the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2006-01-26 | — | — | US | claimed |
| WO-2005079865-A1 | TECHNETIUM- AND RHENIUM-BIS(HETEROARYL) COMPLEXES, AND METHODS OF USE THEREOF | MOLECULAR INSIGHT PHARMACEUTICALS (US) | 2005-09-01 | — | — | WO | claimed |
| WO-2005079866-A1 | TECHNETIUM-AND RHENIUM-BIS(HETEROARYL) COMPLEXES, AND METHODS OF USE THEREOF | MOLECULAR INSIGHT PHARMACEUTICALS (US) | 2005-09-01 | — | — | WO | claimed |
| US-6066642-A | FOR SELECTIVELY BLOCKING THE A3 ADENOSINE RECEPTOR OF A MAMMAL | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-05-23 | — | — | US | claimed |
| EP-0885192-A1 | DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN- ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVE, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 1998-12-23 | — | — | EP | claimed |
| WO-1997027177-A2 | DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN-4-ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-07-31 | — | — | WO | claimed |
| US-4464366-A | Cephem compounds having a terminal aminocarboxylic acid grouping and containing an azacyclyl(thio)ureido group | CIBA GEIGY CORPORATION (US) | 1984-08-07 | — | — | US | claimed |